Remdesivir vs. Hydroxychloroquine - podcast episode cover

Remdesivir vs. Hydroxychloroquine

Jul 07, 202025 minEp. 39
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Remdesivir is an intravenous anti-viral drug being used for the novel coronavirus. It is produced by Gilead Sciences. Hydroxychloroquine is an off-patent, very cheap drug which has been touted by President Trump. Let's look into the science and conflicts of interest between these two drugs. The answers might surprise you...

For the best experience, listen in Metacast app for iOS or Android